Roy Khalife
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Roy Khalife has a total of 107 co-authors. Here are the top co-authors by number of shared publications:
Alan Tinmouth
Département de médecine (Khalife, Tinmouth), division d'hématologie, L'Hôpital d'Ottawa et l'Université d'Ottawa; Département de pathologie et de médecine de laboratoire (Mahdi), Association des laboratoires régionaux de l'Hôpital d'Ottawa et de l'Est de l'Ontario et l'Université d'Ottawa, Ottawa, Ont
11 shared publicationsLisa Duffett
Department of Medicine Division of Hematology University of Ottawa at the Ottawa Hospital Ottawa ON Canada
7 shared publicationsBonnie Niu
Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada
3 shared publicationsCarol Gonsalves
Department of Medicine (Hematology), The Ottawa Hospital University of Ottawa Ottawa Ontario Canada
3 shared publications- Kelsey Uminski
Division of Hematology and Hematologic Malignancies University of Calgary Calgary Alberta Canada
3 shared publications Tzu-Fei Wang
Department of Medicine, Division of Hematology, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada
3 shared publications
Latest Publications
- Open Access
- 30 July 2026
- Published by Wiley in Medical Education
Perceptions and experiences of entrustable professional activities implementation in postgraduate medical education: A qualitative evidence synthesis
Background: Entrustable professional activities (EPAs) define essential professional tasks and responsibilities that can inform curriculum, teaching, supervision, developmental progression and assessment. Despite widespread implementation in postgraduate medical education, experiences and perceptions of EPAs remain fragmented, raising questions about how they are translated into practice. Methods: We conducted a systematic review and qualitative evidence synthesis of studies exploring participant experiences and perceptions of EPA implementation in postgraduate medical education. Six databases were searched from inception to August 2024 and updated in April 2025. Eligible studies included qualitative and mixed‐methods designs that examined learners, faculty, administrators or other groups involved in EPA use. Data were extracted in duplicate and analysed using Thomas and Harden's thematic synthesis approach. Methodological quality was assessed with the Joanna Briggs Institute checklist, and confidence in findings was appraised with the GRADE‐CERQual framework. Results: From 7027 records, 23 studies involving 443 participants were included. Studies spanned Canada, the United States, Europe, and New Zealand across diverse specialties. Thematic synthesis yielded five interrelated themes: design tensions ; growth and performance ; faculty preparedness, engagement and consistency ; psychological climate ; and anchoring in institutional scaffolds . Participants valued EPAs for clarifying expectations, structuring feedback and supporting developmental progression. However, many experiences were shaped by assessment‐dominant implementation, in which EPAs were encountered primarily through forms, entrustment ratings, completion requirements and progression decisions. Administrative burden, faculty uncertainty, learner anxiety and strategic completion contributed to this narrowed enactment. Conclusions: EPAs were often experienced less as broad frameworks for organising professional development and more as assessment infrastructure. Future implementation should focus on translating EPAs as intended: essential professional activities that guide curriculum, supervision, feedback and assessment within supportive educational systems.
- 30 July 2026
- Published by Wiley in Medical Education
Open AccessPerceptions and experiences of entrustable professional activities implementation in postgraduate medical education: A qualitative evidence synthesis
Background: Entrustable professional activities (EPAs) define essential professional tasks and responsibilities that can inform curriculum, teaching, supervision, developmental progression and assessment. Despite widespread implementation in postgraduate medical education, experiences and perceptions of EPAs remain fragmented, raising questions about how they are translated into practice. Methods: We conducted a systematic review and qualitative evidence synthesis of studies exploring participant experiences and perceptions of EPA implementation in postgraduate medical education. Six databases were searched from inception to August 2024 and updated in April 2025. Eligible studies included qualitative and mixed‐methods designs that examined learners, faculty, administrators or other groups involved in EPA use. Data were extracted in duplicate and analysed using Thomas and Harden's thematic synthesis approach. Methodological quality was assessed with the Joanna Briggs Institute checklist, and confidence in findings was appraised with the GRADE‐CERQual framework. Results: From 7027 records, 23 studies involving 443 participants were included. Studies spanned Canada, the United States, Europe, and New Zealand across diverse specialties. Thematic synthesis yielded five interrelated themes: design tensions ; growth and performance ; faculty preparedness, engagement and consistency ; psychological climate ; and anchoring in institutional scaffolds . Participants valued EPAs for clarifying expectations, structuring feedback and supporting developmental progression. However, many experiences were shaped by assessment‐dominant implementation, in which EPAs were encountered primarily through forms, entrustment ratings, completion requirements and progression decisions. Administrative burden, faculty uncertainty, learner anxiety and strategic completion contributed to this narrowed enactment. Conclusions: EPAs were often experienced less as broad frameworks for organising professional development and more as assessment infrastructure. Future implementation should focus on translating EPAs as intended: essential professional activities that guide curriculum, supervision, feedback and assessment within supportive educational systems.
- Open Access
- 11 June 2026
- Published by American Society of Hematology in Blood Advances
- Vol. 10 (15) , 5378-5388
Effect of PCC on Thrombin Generation in Patients on FXaI with Bleeding or Needing Urgent Surgery (GAUGE)
Prothrombin complex concentrates (PCC) are used off-label to treat direct factor Xa inhibitor (FXaI)-associated bleeding or before urgent surgery. GAUGE was a prospective observational cohort study of the effects of PCC on thrombin generation and hemostasis in FXaI-treated patients. FXaI-treated patients with major bleeding or needing urgent surgery received PCC (50 IU/kg). Platelet-poor plasma was collected pre-/post-PCC. TGA parameters (LT=lag time, TTP=time-to-peak, peak, ETP=endogenous thrombin potential, mVRI=mean velocity rate index) were measured using calibrated automated thrombography. Hemostatic efficacy, thromboembolism, and mortality were adjudicated in duplicate. Multivariable log-linear regression was used to evaluate PCC effects on FXaI levels. Unsupervised K-means clustering was used to identify patients with the largest ETP increment. GAUGE included 101 episodes of FXaI-associated PCC use (FXaI-associated bleeding = 71; urgent surgery = 30). Median PCC dosing was 48.0 IU/kg [42.0-50.0]. PCC did not affect FXaI levels (p>0.05). PCC increased ETP (Δ868.9±766.6 nM·min), peak (Δ85.7 nM±108.2), and the mVRI (Δ16.5 nM/min [4.4-45.0]). PCC did not affect the LT or TTP (p>0.05). Patients in Cluster 1 had significantly lower pre-PCC FXaI levels (79 ng/mL [55-93] vs 165 ng/mL [77-219]; p = 0.009) and a greater ΔETP increment (p < 0.0001) than patients in Cluster 2. Effective hemostasis occurred in 50.0% [95%CI 38.4-61.6] of major bleeds; procedural hemostasis was normal in 76.7% [95%CI 59.1-88.2]. The 30-day risks of thromboembolism and mortality were 6.9% [95%CI 3.4-13.6] and 12.9% [95%CI 7.7-20.8], respectively. PCC increased quantitative thrombin generation without shortening LT or TTP, supporting a prohemostatic effect rather than true FXaI reversal.
- 11 June 2026
- Published by American Society of Hematology in Blood Advances
- Vol. 10 (15) , 5378-5388
Open AccessEffect of PCC on Thrombin Generation in Patients on FXaI with Bleeding or Needing Urgent Surgery (GAUGE)
Prothrombin complex concentrates (PCC) are used off-label to treat direct factor Xa inhibitor (FXaI)-associated bleeding or before urgent surgery. GAUGE was a prospective observational cohort study of the effects of PCC on thrombin generation and hemostasis in FXaI-treated patients. FXaI-treated patients with major bleeding or needing urgent surgery received PCC (50 IU/kg). Platelet-poor plasma was collected pre-/post-PCC. TGA parameters (LT=lag time, TTP=time-to-peak, peak, ETP=endogenous thrombin potential, mVRI=mean velocity rate index) were measured using calibrated automated thrombography. Hemostatic efficacy, thromboembolism, and mortality were adjudicated in duplicate. Multivariable log-linear regression was used to evaluate PCC effects on FXaI levels. Unsupervised K-means clustering was used to identify patients with the largest ETP increment. GAUGE included 101 episodes of FXaI-associated PCC use (FXaI-associated bleeding = 71; urgent surgery = 30). Median PCC dosing was 48.0 IU/kg [42.0-50.0]. PCC did not affect FXaI levels (p>0.05). PCC increased ETP (Δ868.9±766.6 nM·min), peak (Δ85.7 nM±108.2), and the mVRI (Δ16.5 nM/min [4.4-45.0]). PCC did not affect the LT or TTP (p>0.05). Patients in Cluster 1 had significantly lower pre-PCC FXaI levels (79 ng/mL [55-93] vs 165 ng/mL [77-219]; p = 0.009) and a greater ΔETP increment (p < 0.0001) than patients in Cluster 2. Effective hemostasis occurred in 50.0% [95%CI 38.4-61.6] of major bleeds; procedural hemostasis was normal in 76.7% [95%CI 59.1-88.2]. The 30-day risks of thromboembolism and mortality were 6.9% [95%CI 3.4-13.6] and 12.9% [95%CI 7.7-20.8], respectively. PCC increased quantitative thrombin generation without shortening LT or TTP, supporting a prohemostatic effect rather than true FXaI reversal.
- Open Access
- 12 April 2026
- Published by CMA Impact Inc. in Canadian Medical Association Journal
- Vol. 198 (14) , E571-E575
Thrombopénie récurrente avec agrégation plaquettaire chez une femme enceinte
- 12 April 2026
- Published by CMA Impact Inc. in Canadian Medical Association Journal
- Vol. 198 (14) , E571-E575
Open AccessThrombopénie récurrente avec agrégation plaquettaire chez une femme enceinte
- Open Access
- 25 January 2026
- Published by CMA Impact Inc. in Canadian Medical Association Journal
- Vol. 198 (3) , E84-E87
Recurrent thrombocytopenia with platelet clumping in a pregnant woman
- 25 January 2026
- Published by CMA Impact Inc. in Canadian Medical Association Journal
- Vol. 198 (3) , E84-E87
Open AccessRecurrent thrombocytopenia with platelet clumping in a pregnant woman
- Open Access
- 6 December 2025
- Published by Elsevier in Hematology, Transfusion and Cell Therapy
- Vol. 48 (1) , 106225
Obstetrical use of intravenous immunoglobulin: A single-centre retrospective study
- 6 December 2025
- Published by Elsevier in Hematology, Transfusion and Cell Therapy
- Vol. 48 (1) , 106225
Open AccessObstetrical use of intravenous immunoglobulin: A single-centre retrospective study
- Open Access
- 23 October 2025
- Published by Springer Nature in Canadian Journal of Emergency Medicine
- Vol. 28 (2) , 100-103
Just the facts: approach to adult patients with immune thrombocytopenic purpura in the emergency department
- 23 October 2025
- Published by Springer Nature in Canadian Journal of Emergency Medicine
- Vol. 28 (2) , 100-103
Open AccessJust the facts: approach to adult patients with immune thrombocytopenic purpura in the emergency department
- Open Access
- 2 September 2025
- Published by Wiley in Haemophilia
- Vol. 31 (5) , 815-822
Bridging the Evidence Gap in von Willebrand Disease: A Call to Action for Equitable, Evidence‐Based Care
- 2 September 2025
- Published by Wiley in Haemophilia
- Vol. 31 (5) , 815-822
Open AccessBridging the Evidence Gap in von Willebrand Disease: A Call to Action for Equitable, Evidence‐Based Care
- 23 June 2025
- Published by Springer Nature in Canadian Journal of Emergency Medicine
- Vol. 27 (12) , 952-956
Just the facts: emergency department approach to vaso-occlusive episodes in sickle cell disease
- 23 June 2025
- Published by Springer Nature in Canadian Journal of Emergency Medicine
- Vol. 27 (12) , 952-956
Just the facts: emergency department approach to vaso-occlusive episodes in sickle cell disease
- 10 May 2025
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 23 (6) , 1771-1773
Navigating the challenges of neuraxial anesthesia in patients with platelet and coagulation disorders: commentary on the ISTH SSC Delphi Consensus recommendations
- 10 May 2025
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 23 (6) , 1771-1773
Navigating the challenges of neuraxial anesthesia in patients with platelet and coagulation disorders: commentary on the ISTH SSC Delphi Consensus recommendations